Research - Munich, Bavaria, Germany
CytoSwitch is a small biotech developer based at the LMU Munich which is developing an innovative technology to fight cancer tumours. It is currently taking its lead drug candidate to preclinical testing in mouse models. In parallel, CytoSwitch is also developing research reagents for the biotech and academic markets. Currently in the pre-seed stage, it is carrying out pre-clinical studies for the next three years (2017-2020) through the EXIST German government funding programme.